Sterling Accuris Diagnostics has announced a strategic alliance with VPL Diagnostic, a specialty allergy testing provider in Ahmedabad. This alliance aims to leverage their mutual synergies for robust growth in the Indian Allergy market, which is expected to undergo a CAGR of 10.9% from 2022-2029.
VPL Diagnostic, with expertise in allergy testing, will benefit from Sterling Accuris’ extensive network of labs and patient service centers, while Sterling Accuris plans to expand its high-end testing services to VPL’s network of clients. The collaboration also aims to introduce specific Microarray based allergy testing and food intolerance, consolidating VPL Diagnostic as a one-stop solution for allergy testing.
Mr. Rajiv Sharma, MD of Sterling Accuris Diagnostics, expressed that “Sterling Accuris has a comprehensive range of test menu, from basic haematology to high end genetics. VPL diagnostic is a highly specialized lab in the field of allergy testing and has more than 500 clients Pan India. This alliance will help us leverage this network of clients to also provide high-end testing services other than allergy testing to them.”
Mr. Ankush Gupta, CEO of Sterling Accuris Diagnostics, said, “As per Data Bridge Model Research, the Indian Allergy market is expected to undergo a CAGR of 10.9% during the forecast period of 2022-2029. Through this strategic alliance with VPL diagnostic, both companies aim to leverage mutual synergies for strong growth.”
Mr. Unmil Shah, MD of VPL Diagnostic, stated, “VPL Pathology Lab is renowned for our expertise in allergy testing, and our collaboration with Sterling Accuris opens exciting new horizons for us. Sterling Accuris’ extensive network of labs and patient service centers will make our presence across the states, firmly establishing our leadership in the allergy testing domain.”
Mrs. Nirvi Shah, Head Business Operations of VPL Diagnostic stated, “Alliance with Sterling Accuris will help us consolidate our presence in direct to customer segment. Collectively both the companies will work towards introducing specific Microarray based allergy testing and food intolerance making VPL diagnostic one stop solution for allergy testing.”
The partnership solidifies Sterling Accuris’ strong presence in the diagnostics industry, providing an opportunity to enhance its medical and healthcare offerings and expand its customer base. The collaboration with VPL Diagnostic forms part of a broader trend of partnerships in the healthcare sector, indicating an industry-wide strategy to strengthen and expand service offerings